Latest Breaking News On - Vivos therapeutics company profile - Page 1 : vimarsana.com

Vivos Therapeutics, Inc (NASDAQ:VVOS) Short Interest Update

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 46,400 shares, a decline of 26.1% from the April 30th total of 62,800 shares. Based on an average daily volume of 170,200 shares, the short-interest ratio […]

Vivos therapeutics incArmistice capitalSecurities exchange commissionVivos therapeutics company profileVivos therapeuticsGet free reportFree reportVivos methodVivos therapeutics daily

Vivos Therapeutics, Inc (NASDAQ:VVOS) Sees Large Drop in Short Interest

Vivos Therapeutics, Inc (NASDAQ:VVOS) Sees Large Drop in Short Interest
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Armistice capitalVivos therapeutics company profileVivos therapeutics incExchange commissionVivos therapeuticsGet free reportFree reportVivos methodVivos therapeutics daily

Vivos Therapeutics, Inc (NASDAQ:VVOS) Sees Large Decrease in Short Interest

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decrease of 45.1% from the March 15th total of 263,500 shares. Based on an average daily trading volume, of 760,200 shares, the days-to-cover ratio […]

Vivos therapeutics company profileVanguard group incSeacrest wealth managementRenaissance technologiesVivos therapeutics incVivos therapeuticsGet ratingCapital marketsCrest wealth managementStreet corpVivos systemVivos therapeutics dailyNasdaq vvos

Vivos Therapeutics, Inc (NASDAQ:VVOS) Short Interest Update

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decline of 45.1% from the March 15th total of 263,500 shares. Based on an average daily volume of 760,200 shares, the short-interest ratio is […]

Vanguard group incSeacrest wealth managementRenaissance technologiesVivos therapeutics incVivos therapeutics company profileVivos therapeuticsGet ratingCapital marketsCrest wealth managementStreet corpVanguard groupVivos systemVivos therapeutics dailyNasdaq vvos